{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:22:13Z","timestamp":1779909733578,"version":"3.53.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["PIBIT 2024\/2025"],"award-info":[{"award-number":["PIBIT 2024\/2025"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["180151\/2024-0"],"award-info":[{"award-number":["180151\/2024-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["444941\/2023-1"],"award-info":[{"award-number":["444941\/2023-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["406436\/2022\\u20133"],"award-info":[{"award-number":["406436\/2022\\u20133"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.micpath.2026.108371","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T07:54:05Z","timestamp":1770710045000},"page":"108371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Microparticles against leishmaniasis: Advances, challenges, and perspectives in modified drug delivery systems"],"prefix":"10.1016","volume":"213","author":[{"given":"Laiene Antunes","family":"Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraia","family":"de Oliveira Simi\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00eds Salvador","family":"do Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul Edison","family":"Luna Lazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel Henrique","family":"Marcondes Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pontarolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9951-587X","authenticated-orcid":false,"given":"Luana Mota","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2026.108371_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5278518","article-title":"Quinine sulphate microparticles as treatment for leishmaniasis","volume":"2020","author":"Allotey-Babington","year":"2020","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.micpath.2026.108371_bib2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1128\/AAC.50.4.1195-1201.2006","article-title":"Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation","volume":"50","author":"I\u00f1iguez","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108371_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000371391","article-title":"Biodegradable microparticles containing crotamine isolated from Crotalus durissus terrificus display antileishmanial activity in vitro","volume":"95","author":"Macedo","year":"2015","journal-title":"Pharmacology"},{"key":"10.1016\/j.micpath.2026.108371_bib4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3762\/bjoc.15.58","article-title":"Design and synthesis of multivalent \u03b1-1,2-trimannose-linked bioerodible microparticles for applications in immune response studies of Leishmania major infection","volume":"15","author":"Rintelmann","year":"2019","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.micpath.2026.108371_bib5","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/03639045.2018.1461903","article-title":"Improved drug loading via spray drying of a chalcone implant for local treatment of cutaneous leishmaniasis","volume":"44","author":"Sousa-Batista","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.micpath.2026.108371_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/02652048.2017.1280094","article-title":"Assessment of formulated amodiaquine microparticles in Leishmania donovani infected rats","volume":"34","author":"Nettey","year":"2017","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.micpath.2026.108371_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijpharm.2016.01.004","article-title":"Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles","volume":"499","author":"Collier","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2026.108371_bib8","article-title":"Oral amodiaquine microparticles repurposed for the treatment of visceral leishmaniasis","volume":"17","author":"Nettey","year":"2022","journal-title":"Sci. Afr."},{"key":"10.1016\/j.micpath.2026.108371_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010051","article-title":"In vivo safety and efficacy of chalcone-loaded microparticles with modified polymeric matrix against cutaneous leishmaniasis","volume":"15","author":"Sousa-Batista","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2026.108371_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/10611860500097107","article-title":"Influence of the vehicle on the properties and efficacy of microparticles containing amphotericin B","volume":"13","author":"S\u00e1nchez-Brunete","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.micpath.2026.108371_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01822-17","article-title":"Depot subcutaneous injection with chalcone CH8-Loaded Poly(Lactic-Co-Glycolic acid) microspheres as a single-dose treatment of cutaneous leishmaniasis","volume":"62","author":"Sousa-Batista","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108371_bib12","article-title":"Evaluation of the antileishmanial activity of biodegradable microparticles containing a hexanic eluate subfraction of Maytenus guianensis bark","volume":"205","author":"Macedo","year":"2019","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2026.108371_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.parint.2015.10.007","article-title":"Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection","volume":"65","author":"Hoseini","year":"2016","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.micpath.2026.108371_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3161045","article-title":"Antileishmanial and immunomodulatory effect of babassu-loaded PLGA microparticles: a useful drug target to Leishmania amazonensis infection","volume":"2018","author":"Da Silva","year":"2018","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.micpath.2026.108371_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/1061186031000119101","article-title":"Phospholipid microspheres: a novel delivery mode for targeting antileishmanial agent in experimental leishmaniasis","volume":"11","author":"Medda","year":"2003","journal-title":"J. Drug Target."},{"key":"10.1016\/j.micpath.2026.108371_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","article-title":"Guidance for conducting systematic scoping reviews","volume":"13","author":"Peters","year":"2015","journal-title":"Int. J. Evid. Based. Healthc."},{"key":"10.1016\/j.micpath.2026.108371_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.micpath.2026.108371_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.micpath.2026.108371_bib20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.2042-7158.1987.tb05126.x","article-title":"Biodegradable microspheres: polyacryl starch microparticles as a delivery system for the antileishmanial drug, sodium stibogluconate","volume":"39","author":"Baillie","year":"1987","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108371_bib21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-3156.2004.01296.x","article-title":"Anti-leishmanial activity of a new formulation of amphotericin B","volume":"9","author":"Dea-Ayuela","year":"2004","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.micpath.2026.108371_bib22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1023\/A:1018936522266","article-title":"Interferon-\u03b3 in starch microparticles: Nitric oxide-generating activity in vitro and antileishmanial effect in mice","volume":"10","author":"Degling","year":"1993","journal-title":"Pharm. Res.: An Official Journal of the American Association of Pharmaceutical Scientists"},{"key":"10.1016\/j.micpath.2026.108371_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.arcmed.2011.11.005","article-title":"Immunomodulatory activities of chitin microparticles on Leishmania major-infected murine macrophages","volume":"42","author":"Dehghani","year":"2011","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.micpath.2026.108371_bib24","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1021\/mp3005098","article-title":"Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis","volume":"10","author":"Duong","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.micpath.2026.108371_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.parint.2014.12.007","article-title":"Immunomodulatory effects of chitin microparticles on Leishmania major-infected BALB\/c mice","volume":"64","author":"Ghotloo","year":"2015","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.micpath.2026.108371_bib26","first-page":"150","article-title":"Synthesis of antileishmanial (5R)-(-)-5-Carbomethoxy-3-formyl-5,6- dihydroindolo-[2,3-a]-indolizine","author":"Jaisankar","year":"2003","journal-title":"Request PDF, Archive for Organic Chemistry"},{"key":"10.1016\/j.micpath.2026.108371_bib27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/dta.389","article-title":"Paromomycin-loaded albumin microspheres: efficacy and stability studies","volume":"5","author":"Khan","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.micpath.2026.108371_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/02652048.2011.559281","article-title":"Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasis","volume":"28","author":"Kunjachan","year":"2011","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.micpath.2026.108371_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijantimicag.2007.05.013","article-title":"In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum","volume":"30","author":"Ord\u00f3\u00f1ez-Guti\u00e9rrez","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2026.108371_bib30","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00436-008-0901-z","article-title":"In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum","volume":"102","author":"Pujals","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.micpath.2026.108371_bib31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2014.07.004","article-title":"New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp","volume":"473","author":"Ruiz","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2026.108371_bib32","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1128\/AAC.48.9.3246-3252.2004","article-title":"Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres","volume":"48","author":"S\u00e1nchez-Brunete","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108371_bib33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/106118021000072681","article-title":"Quercetin: critical evaluation as an antileishmanial agent in vivo in hamsters using different vesicular delivery modes","volume":"10","author":"Sarkar","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.micpath.2026.108371_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1166\/jbn.2011.1237","article-title":"Development and characterization of doxorubicin loaded microparticles against experimental visceral leishmaniasis","volume":"7","author":"Sharma","year":"2011","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.micpath.2026.108371_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1166\/jbn.2011.1196","article-title":"Design and development of Amphotericin B bearing polycaprolactone microparticles for macrophage targeting","volume":"7","author":"Singh","year":"2011","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.micpath.2026.108371_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/107175402753413181","article-title":"Bacopasaponin C: critical evaluation of anti-leishmanial properties in various delivery modes","volume":"9","author":"Sinha","year":"2002","journal-title":"Drug Deliv."},{"key":"10.1016\/j.micpath.2026.108371_bib37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpddr.2019.06.001","article-title":"Novel and safe single-dose treatment of cutaneous leishmaniasis with implantable amphotericin B-loaded microparticles","volume":"11","author":"Sousa-Batista","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.micpath.2026.108371_bib38","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1017\/S0031182020000712","article-title":"Single-dose treatment for cutaneous leishmaniasis with an easily synthesized chalcone entrapped in polymeric microparticles","volume":"147","author":"Sousa-Batista","year":"2020","journal-title":"Parasitology"},{"key":"10.1016\/j.micpath.2026.108371_bib39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0378-5173(87)90171-2","article-title":"Biodegradable microspheres. VIII. Killing of Leishmania donovani in cultured macrophages by microparticle-bound primaquine","volume":"40","author":"Stj\u00e4rnkvist","year":"1987","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2026.108371_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0378-5173(93)90208-W","article-title":"Biodegradable microspheres: XIV. Effect of microparticle-bound primaquine on L. donovani in mice","volume":"96","author":"Stj\u00e4rnkvist","year":"1993","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2026.108371_bib41","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/polym13081209","article-title":"Emerging biofabrication techniques: a review on natural polymers for biomedical applications","volume":"13","author":"Puertas-Bartolom\u00e9","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.micpath.2026.108371_bib42","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3390\/polym14061208","article-title":"Research on the application of synthetic polymer materials in contemporary public art","volume":"14","author":"Zhang","year":"2022","journal-title":"Polymers"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026000975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026000975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:58:50Z","timestamp":1776178730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026000975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":41,"alternative-id":["S0882401026000975"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108371","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microparticles against leishmaniasis: Advances, challenges, and perspectives in modified drug delivery systems","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108371"}}